COVID-19 patients, particularly those with severe COVID-19, show impaired antiviral responses with decreased CD3+ T cells and NK cells, reduced perforin and granzyme A expression, and increased IL-6 serum levels20. This evidence concerns the gene PRF1 and COVID-19.